Transgenomic, Inc. (TBIO) and the Medical College of Wisconsin Announce Collaboration to Provide Next-Generation Sequencing Testing  
7/30/2012 9:38:24 AM

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTC/BB: TBIO) and the Medical College of Wisconsin (MCW) today announced a collaboration agreement under which Transgenomic will offer next-generation genetic testing services performed at the MCW Clinical Sequencing Program. These services will initially include Transgenomic’s NuclearMitome Test for mitochondrial disorders.